AR111416A2 - THERAPEUTIC COMPOUND FOR THE PAIN AND SYNTHESIS OF THE COMPOUND - Google Patents
THERAPEUTIC COMPOUND FOR THE PAIN AND SYNTHESIS OF THE COMPOUNDInfo
- Publication number
- AR111416A2 AR111416A2 ARP180101035A ARP180101035A AR111416A2 AR 111416 A2 AR111416 A2 AR 111416A2 AR P180101035 A ARP180101035 A AR P180101035A AR P180101035 A ARP180101035 A AR P180101035A AR 111416 A2 AR111416 A2 AR 111416A2
- Authority
- AR
- Argentina
- Prior art keywords
- compound
- compounds
- pain
- synthesis
- pharmaceutically acceptable
- Prior art date
Links
- 150000001875 compounds Chemical class 0.000 title abstract 7
- 230000015572 biosynthetic process Effects 0.000 title 1
- 238000003786 synthesis reaction Methods 0.000 title 1
- 230000001225 therapeutic effect Effects 0.000 title 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 2
- 150000003839 salts Chemical class 0.000 abstract 2
- 201000010099 disease Diseases 0.000 abstract 1
- 208000035475 disorder Diseases 0.000 abstract 1
- 239000000203 mixture Substances 0.000 abstract 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
Landscapes
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Hydrogenated Pyridines (AREA)
Abstract
La presente solicitud proporciona compuestos, estereoisómeros, sales farmacéuticamente aceptables y derivados de estos; y métodos para elaborar y usar tales compuestos. Se incluye composiciones farmacéuticas que contienen tales compuestos, y el uso de estos compuestos en métodos para tratar afecciones, enfermedades o trastornos. Reivindicación 1: Un compuesto caracterizado porque tiene la fórmula seleccionada del grupo de fórmulas (1), o sal farmacéuticamente aceptable, o mezcla de los mismos.The present application provides compounds, stereoisomers, pharmaceutically acceptable salts and derivatives thereof; and methods for making and using such compounds. It includes pharmaceutical compositions containing such compounds, and the use of these compounds in methods to treat conditions, diseases or disorders. Claim 1: A compound characterized in that it has the formula selected from the group of formulas (1), or pharmaceutically acceptable salt, or mixture thereof.
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201562214727P | 2015-09-04 | 2015-09-04 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AR111416A2 true AR111416A2 (en) | 2019-07-10 |
Family
ID=60452274
Family Applications (9)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ARP160102708A AR105921A1 (en) | 2015-09-04 | 2016-09-05 | THERAPEUTIC COMPOUNDS FOR PAIN AND SYNTHESIS OF THESE |
| ARP160102711A AR105924A1 (en) | 2015-09-04 | 2016-09-05 | THERAPEUTIC COMPOUNDS AND SYNTHESIS |
| ARP160102710A AR105923A1 (en) | 2015-09-04 | 2016-09-05 | THERAPEUTIC COMPOUNDS FOR PAIN AND SYNTHESIS OF THESE |
| ARP160102707A AR105920A1 (en) | 2015-09-04 | 2016-09-05 | THERAPEUTIC COMPOUND FOR THE PAIN AND SYNTHESIS OF THE COMPOUND |
| ARP160102709A AR105922A1 (en) | 2015-09-04 | 2016-09-05 | 1 - ((6-METOXINAFTALEN-2-IL) METHYL) -4- (3,3,3-TRIFLUOROPROPANOIL) OCTAHIDRO-1H-2,6-METANOPIRROLO [3,2-B] PIRIDIN-3-IL-USEFUL PIVALATE IN PAIN TREATMENT |
| ARP180101035A AR111416A2 (en) | 2015-09-04 | 2018-04-23 | THERAPEUTIC COMPOUND FOR THE PAIN AND SYNTHESIS OF THE COMPOUND |
| ARP180101047A AR113298A2 (en) | 2015-09-04 | 2018-04-24 | METHOD FOR PREPARING A BRIDGED DERIVATIVE OF PIVALATE FROM SPOOLAMINE |
| ARP180101062A AR111424A2 (en) | 2015-09-04 | 2018-04-25 | PREPARATION METHOD OF 1 - ((6-METOXINAFTALEN-2-IL) METHYL) -4- (3,3,3-TRIFLUROPROPANOL) OCTAHIDRO-1H-2,6-METANOPIRROLO [3,2-B] PIRIDIN-3- IL PIVALATO |
| ARP180101061A AR111423A2 (en) | 2015-09-04 | 2018-04-25 | THERAPEUTIC COMPOUNDS FOR PAIN AND SYNTHESIS OF THESE |
Family Applications Before (5)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ARP160102708A AR105921A1 (en) | 2015-09-04 | 2016-09-05 | THERAPEUTIC COMPOUNDS FOR PAIN AND SYNTHESIS OF THESE |
| ARP160102711A AR105924A1 (en) | 2015-09-04 | 2016-09-05 | THERAPEUTIC COMPOUNDS AND SYNTHESIS |
| ARP160102710A AR105923A1 (en) | 2015-09-04 | 2016-09-05 | THERAPEUTIC COMPOUNDS FOR PAIN AND SYNTHESIS OF THESE |
| ARP160102707A AR105920A1 (en) | 2015-09-04 | 2016-09-05 | THERAPEUTIC COMPOUND FOR THE PAIN AND SYNTHESIS OF THE COMPOUND |
| ARP160102709A AR105922A1 (en) | 2015-09-04 | 2016-09-05 | 1 - ((6-METOXINAFTALEN-2-IL) METHYL) -4- (3,3,3-TRIFLUOROPROPANOIL) OCTAHIDRO-1H-2,6-METANOPIRROLO [3,2-B] PIRIDIN-3-IL-USEFUL PIVALATE IN PAIN TREATMENT |
Family Applications After (3)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ARP180101047A AR113298A2 (en) | 2015-09-04 | 2018-04-24 | METHOD FOR PREPARING A BRIDGED DERIVATIVE OF PIVALATE FROM SPOOLAMINE |
| ARP180101062A AR111424A2 (en) | 2015-09-04 | 2018-04-25 | PREPARATION METHOD OF 1 - ((6-METOXINAFTALEN-2-IL) METHYL) -4- (3,3,3-TRIFLUROPROPANOL) OCTAHIDRO-1H-2,6-METANOPIRROLO [3,2-B] PIRIDIN-3- IL PIVALATO |
| ARP180101061A AR111423A2 (en) | 2015-09-04 | 2018-04-25 | THERAPEUTIC COMPOUNDS FOR PAIN AND SYNTHESIS OF THESE |
Country Status (1)
| Country | Link |
|---|---|
| AR (9) | AR105921A1 (en) |
-
2016
- 2016-09-05 AR ARP160102708A patent/AR105921A1/en unknown
- 2016-09-05 AR ARP160102711A patent/AR105924A1/en unknown
- 2016-09-05 AR ARP160102710A patent/AR105923A1/en unknown
- 2016-09-05 AR ARP160102707A patent/AR105920A1/en unknown
- 2016-09-05 AR ARP160102709A patent/AR105922A1/en unknown
-
2018
- 2018-04-23 AR ARP180101035A patent/AR111416A2/en not_active Application Discontinuation
- 2018-04-24 AR ARP180101047A patent/AR113298A2/en not_active Application Discontinuation
- 2018-04-25 AR ARP180101062A patent/AR111424A2/en not_active Application Discontinuation
- 2018-04-25 AR ARP180101061A patent/AR111423A2/en not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| AR105923A1 (en) | 2017-11-22 |
| AR105921A1 (en) | 2017-11-22 |
| AR105922A1 (en) | 2017-11-22 |
| AR113298A2 (en) | 2020-04-08 |
| AR105924A1 (en) | 2017-11-22 |
| AR111424A2 (en) | 2019-07-10 |
| AR105920A1 (en) | 2017-11-22 |
| AR111423A2 (en) | 2019-07-10 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CO2019013021A2 (en) | Deuterated pyridone amides and their prodrugs as modulators of sodium channels | |
| CL2019001077A1 (en) | 6,7,8,9-tetrahydro-3h-pyrazolo [4,3-f] isoquinoline derivatives useful in the treatment of cancer. | |
| CU20150014A7 (en) | 1,4-DISPOSED PIRIDAZINE ANALOGS AND METHODS FOR THE TREATMENT OF CONDITIONS RELATED TO THE DEFICIENCY OF SMN | |
| MX2016001400A (en) | 1,4-disubstituted pyridazine derivatives and their use for treating smn-deficiency-related conditions. | |
| AR093244A1 (en) | SUBSTITUTED BENZENE COMPOUNDS USED IN THE TREATMENT OF EZH2-DISORDERS | |
| UY36573A (en) | BICYCLIC COMPOUNDS OF SULFONAMIDE KETONE | |
| MX2018001193A (en) | 1,3,4-oxadiazole sulfonamide derivative compounds as histone deacetylase 6 inhibitor, and the pharmaceutical composition comprising the same. | |
| AR108046A1 (en) | INDOLINA DERIVATIVES REPLACED AS INHIBITORS OF THE VIRAL REPLICATION OF DENGUE | |
| UY35273A (en) | TIADIAZOL, ANALOGS OF THE SAME, AND METHODS FOR THE TREATMENT OF CONDITIONS RELATED TO DEFICIENT OF SMN | |
| CL2020001097A1 (en) | Pyridinecarbonyl derivatives and therapeutic uses thereof as trpc6 inhibitors. | |
| MX2019000451A (en) | HETEROCYCLIC COMPOUND USED AS AN INHIBITOR OF FGFR. | |
| AR093705A1 (en) | DEPSIPEPTIDE AND ITS USES | |
| UY31885A (en) | DERIVED FROM THE 1, 3, 5-TRIAZINA-2, 4-DIAMINAS-6-SUBSTITUTED-N-SUBSTITUTED AND PHARMACEUTICALLY ACCEPTABLE SALTS OF THE SAME, COMPOSITIONS AND APPLICATIONS. | |
| UY37837A (en) | NEW HETEROCYCLIC COMPOUNDS AS INHIBITORS OF CDK8 / 19 | |
| UY36875A (en) | BROMODOMINIUM INHIBITING COMPOSITIONS FOR THE TREATMENT OF VARIOUS DISEASES | |
| UY36124A (en) | CARBOXAMIDE DERIVATIVES | |
| CO2020005944A2 (en) | Amine-substituted heterocyclic compounds as ehmt2 inhibitors, salts thereof, and methods of synthesis thereof | |
| CO2018007436A2 (en) | Alkyl dihydroquinolinsulfonamide compounds | |
| MX384293B (en) | Blood-brain barrier penetrating dopamine-b-hydroxylase inhibitors | |
| UY36123A (en) | CARBOXAMIDE DERIVATIVES | |
| AR102246A1 (en) | AROMATIC COMPOUNDS REPLACED AND PHARMACEUTICAL COMPOSITIONS FOR THE PREVENTION AND TREATMENT OF OSTEOPOROSIS, USES | |
| ECSP19084722A (en) | 5,6-FUSED BICYCLIC COMPOUNDS AND COMPOSITIONS FOR THE TREATMENT OF PARASITIC DISEASES | |
| CL2021000282A1 (en) | Ckd8 / 19 inhibitors | |
| UY38133A (en) | NEW INHIBITORS FROM CDK8 / 19 | |
| AR111416A2 (en) | THERAPEUTIC COMPOUND FOR THE PAIN AND SYNTHESIS OF THE COMPOUND |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FA | Abandonment or withdrawal |